Monoclonal Antibody Treatments for Migraines
he next few years hold promise for “exciting” developments in treating migraines, according to Peter J. Goadsby, MD, of the University of California San Francisco.
he next few years hold promise for “exciting” developments in treating migraines, according to Peter J. Goadsby, MD, of the University of California San Francisco.